1型糖尿病胰岛素泵治疗者运动后低剂量胰高血糖素升糖反应仍保留
骑行后升糖增量峰值高于静息后,骑行前给药减轻运动期间血糖下降,但低血糖事件数无显著差异。
要点
- 45分钟中等强度骑行后注射200 μg胰高血糖素,升糖反应不劣于静息后。
- 骑行前注射200 μg胰高血糖素可减轻运动期间血糖下降。
- 骑行前给药未显著减少低血糖事件数。
核心结论
- 45分钟中等强度骑行未削弱200 μg胰高血糖素的升糖反应;骑行前给药减轻运动期血糖下降,但低血糖事件数无显著差异。
主要发现
- 骑行后胰高血糖素升糖增量峰值为2.6 ± 1.7 mmol/l,静息后为1.8 ± 2.0 mmol/l(p = 0.02)。
- 骑行期间血浆葡萄糖下降-3.1 ± 2.8 mmol/l,骑行前给胰高血糖素时下降-0.9 ± 2.8 mmol/l(p = 0.002)。
- 三天中达到血糖≤3.9 mmol/l的人数相同。
临床怎么用
- 提示运动后使用200 μg胰高血糖素纠正低血糖的升糖反应仍保留,运动前给药可减轻运动期血糖下降但低血糖事件数未见显著减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: This study aimed to compare the increase in plasma glucose after a subcutaneous injection of 200 μg glucagon given after 45 min of cycling with resting (study 1) and to investigate the effects of glucagon when injected before compared with after 45 min of cycling (study 2). We hypothesised that: (1) the glucose response to glucagon would be similar after cycling and resting; and (2) giving glucagon before the activity would prevent the exercise-induced fall in blood glucose during exercise and for 2 h afterwards. METHODS: Fourteen insulin-pump-treated individuals with type 1 diabetes completed three visits in a randomised, placebo-controlled, participant-blinded crossover study. They were allocated by sealed envelopes. Baseline values were (mean and range): HbA1c 54 mmol/mol (43-65 mmol/mol) or 7.1% (6.1-8.1%); age 45 years (23-66 years); BMI 26 kg/m2 (21-30 kg/m2); and diabetes duration 26 years (8-51 years). At each visit, participants consumed a standardised breakfast 2 h prior to 45 min of cycling or resting. A subcutaneous injection of 200 μg glucagon was given before or after cycling or after resting. The glucose response to glucagon was compared after cycling vs resting (study 1) and before vs after cycling (study 2). RESULTS: The glucose response to glucagon was higher after cycling compared with after resting (mean ± SD incremental peak: 2.6 ± 1.7 vs 1.8 ± 2.0 mmol/l, p = 0.02). As expected, plasma glucose decreased during cycling (-3.1 ± 2.8 mmol/l) but less so when glucagon was given before cycling (-0.9 ± 2.8 mmol/l, p = 0.002). The number of individuals reaching glucose values ≤3.9 mmol/l was the same on the 3 days. CONCLUSIONS/INTERPRETATION: Moderate cycling for 45 min did not impair the glucose response to glucagon compared with the glucose response after resting. The glucose fall during cycling was diminished by a pre-exercise injection of 200 μg glucagon; however, no significant difference was seen in the number of events of hypoglycaemia. TRIAL REGISTRATION: Clinicaltrials.gov NCT02882737 FUNDING: The study was funded by the Danish Diabetes Academy founded by Novo Nordisk foundation and by an unrestricted grant from Zealand Pharma.
引用
- Steineck IIK, Ranjan A, Schmidt S, et al. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study. Diabetologia. 2019. PMID: 30643924. doi:10.1007/s00125-018-4807-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。